🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

US STOCKS-Shares set to open slightly higher, earnings eyed

Published 04/11/2011, 09:06 AM
Updated 04/11/2011, 09:08 AM
NDX
-
US500
-
AA
-
BIIB
-
NYX
-
BIG
-
PMCN
-

* Alcoa unofficially kicks off earnings season

* Strong quake in Japan adds to investor caution

* China posts Q1 trade deficit in a sign of rebalancing

* Futures up: S&P 2 pts, Dow 15 pts, Nasdaq 7.75 pts (Updates throughout)

By Angela Moon

NEW YORK, April 11 (Reuters) - Wall Street stocks were set for a slightly higher open on Monday on hopes of strong corporate earnings.

Aluminum maker Alcoa will unofficially kick off the quarterly earnings season after the market's close on Monday. The company is expected to report quarterly earnings of 27 cents per share on revenue of $6.07 billion, according to Thomson Reuters estimates. Investors will be alert for companies' trimming their outlooks due to inflation worries.

"Pricing power. Those two magic words will be ever so important for those companies that rely on raw materials as an input cost as we ready ourselves for earnings reports from corporate America," said Peter Boockvar, equity strategist at Miller Tabak + Co in New York.

"With profit margins at about record highs, the ability to pass through higher costs will be the key factor on whether this can be sustained."

Market reaction was relatively calm after another strong aftershock struck northeast Japan on Monday and the evacuation zone around a crippled nuclear plant was expanded.

NYSE Euronext said it would stick to a deal with Deutsche Boerse, snubbing a rival U.S. offer and thereby decreasing the chances of a bidding war. On Sunday, NYSE Euronext's board of directors unanimously rejected the rival offer from Nasdaq OMX Group and IntercontinentalExchange, saying it was too risky and counter to the Big Board's vision.

NYSE Euronext shares fell 1.2 percent to $38.25 before the bell. Deutsche Boerse shares in Germany rose more than 1 percent.

Shares of Biogen Idec Inc rose 6.1 percent to $77.75 in premarket trading after the company's experimental multiple sclerosis drug met the main goal in the first of two important late-stage studies.

Endo Pharmaceuticals Holding Inc said it will acquire American Medical Systems Holdings Inc, a urological medical devices supplier, for about $2.6 billion in cash to strengthen its core urology franchise.

Shares of Endo rose 6.5 percent to $43.50 in light premarket trading while American Medical was up 32.4 percent at $29.56.

U.S. President Barack Obama will lay out his approach for long-term deficit reduction later this week, his senior adviser David Plouffe said on Sunday. Obama will look at the Medicare and Medicaid government healthcare programs for the elderly and the poor to "see what kind of savings" are possible, Plouffe told NBC's "Meet the Press."

S&P 500 futures rose 2 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures added 15 points and Nasdaq 100 futures rose 7.75 points.

After three months of solid gains that have brought stocks to 2 1/2-year highs, some analysts said the U.S. earnings season may not be the time for investors to buy aggressively since this year's winners already reflect earnings optimism.

Brent crude fell below $125 a barrel, while U.S. crude futures slipped more than $1 a barrel. Forces loyal to Muammar Gaddafi shelled the town of Misrata after the African Union said he had accepted a plan to end Libya's civil war.

U.S. stocks fell late on Friday as a spike in oil prices revived worries that inflation would derail the recovery, jolting a market that had been treading water ahead of corporate earnings. (Reporting by Angela Moon, Editing by Kenneth Barry)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.